LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.62 | 21.74 | 5313 | 4150 | 1.2800 | 1.0662 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.62 | 21.74 | 4500 | 4150 | 1.0841 | 1.0214 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.62 | 21.74 | 4634 | 4150 | 1.1164 | 1.0293 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.62 | 21.74 | 188 | 4150 | 0.0453 | 0.3294 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 45.62 | 21.74 | 5055 | 4150 | 1.2178 | 1.0527 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.59 | 21.74 | 213 | 4492 | 0.0474 | 0.3455 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.59 | 21.74 | 5435 | 4492 | 1.2099 | 1.0502 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.59 | 21.74 | 27 | 4492 | 0.0060 | 0.0286 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.59 | 21.74 | 5672 | 4492 | 1.2627 | 1.0616 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.59 | 21.74 | 4551 | 4492 | 1.0131 | 1.0034 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.59 | 21.74 | 5046 | 4492 | 1.1233 | 1.0305 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.59 | 21.74 | 170 | 4492 | 0.0378 | 0.3066 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 47.59 | 21.74 | 5427 | 4492 | 1.2081 | 1.0498 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.56 | 21.74 | 272 | 4838 | 0.0562 | 0.3827 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.56 | 21.74 | 5806 | 4838 | 1.1999 | 1.0473 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.56 | 21.74 | 31 | 4838 | 0.0064 | 0.0466 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.56 | 21.74 | 6170 | 4838 | 1.2751 | 1.0633 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.56 | 21.74 | 5298 | 4838 | 1.0949 | 1.0234 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.56 | 21.74 | 5457 | 4838 | 1.1278 | 1.0311 | MN20160310_N01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.56 | 21.74 | 191 | 4838 | 0.0395 | 0.3214 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 49.56 | 21.74 | 5910 | 4838 | 1.2214 | 1.0520 | MN20160310_N01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 51.53 | 21.74 | 318 | 5150 | 0.0617 | 0.4051 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 51.53 | 21.74 | 6271 | 5150 | 1.2175 | 1.0505 | MN20160310_N01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 51.53 | 21.74 | 39 | 5150 | 0.0076 | 0.0769 | MN20160310_N01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 51.53 | 21.74 | 6701 | 5150 | 1.3010 | 1.0678 | MN20160310_N01 | J19 |